管理重叠:同时患有牛皮和亚托皮皮炎的患者的治疗方法 - 一个案例系列
Maria Beatrice de Felici Del Giudice1, Giorgia Ravaglia1, Marco Brusasco2
1Dermatology Unit, Department of Medicine and Surgery, University of Parma, I-43121 Parma, Italy.
Journal of clinical medicine
|February 13, 2025
概括
牛皮和亚托邦性皮肤炎可以重叠,产生"牛皮皮肤炎". 雅努斯激酶抑制剂 (JAK-i) 和IL-23抗剂为这种情况提供了治疗选择,每种疗法都有不同的效果和安全性.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 翻译医学是一种翻译医学.
- 临床治疗学 临床治疗学
背景情况:
- 牛皮 (PSO) 和亚型皮肤炎 (AD) 传统上被视为分别是Th1和Th2介导的不同疾病.
- 新出现的证据揭示了像"牛皮皮炎"这样的重叠,有时是由针对一种疾病的疗法诱导的,揭示了另一种疾病的途径.
- 治疗AD的治疗干预措施 (抗IL-4/IL-13) 可以引发牛皮形反应,而PSO治疗 (抗TNFα,抗IL-17) 可能会引起湿疹变化.
研究的目的:
- 探索治疗策略来管理牛皮皮炎,这是PSO和AD的重叠状况.
- 评估Janus激酶抑制剂 (JAK-i) 和IL-23抗剂在治疗牛皮皮炎中的疗效和安全性.
- 介绍一系列案例,说明为这种复杂的皮肤病呈现量身定制的治疗方法.
主要方法:
- 分析了5名患有牛皮皮炎的患者的病例系列.
- 治疗策略是根据患者个人资料,并发病症和疾病特征进行个性化的.
- 考虑了JAK抑制剂和IL-23抗剂的免疫调节作用和安全概况.
主要成果:
- 无论是JAK抑制剂还是IL-23抗剂,都证明了它们作为牛皮皮炎的治疗选择的有效性.
- 雅克抑制剂提供广泛的免疫调节,但由于潜在的不良事件,需要仔细监测.
- IL-23对抗剂提供针对性抑制IL-23/IL-17轴,可能提供更安全的配置.
结论:
- 雅克抑制剂和IL-23抗剂是牛皮皮炎的可行的治疗方法,在免疫调节机制和安全性上有所不同.
- 需要进一步的研究来阐明特定的免疫路径,并确定牛皮皮炎的生物标志物.
- 优化牛皮皮炎的治疗策略需要更深入地了解其潜在的免疫生物学.
更多相关视频
相关概念视频
Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
Inflammatory Bowel Disease IV: Pharmacological Management
99
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
99
T Cell Types and Functions
938
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
938
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Hypersensitivities
488
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
488
COPD: Management Using Bronchodilators and Corticosteroids
174
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
174


